Yu‐ichi Ozaki

Nature Cell Biology · 2005

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Whom Yu‐ichi Ozaki trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Joseph Schlessinger

Who trusts Yu‐ichi Ozaki overall

  1. Boris N. Kholodenko

Papers from Yu‐ichi Ozaki's perspective

Ordered by how strongly the researchers Yu‐ichi Ozaki trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. (Cell)
  2. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. (Cell)
  3. Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints (Nature Communications)
  4. Regulation of Raf-1 by direct feedback phosphorylation. (Molecules and Cells)
  5. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha.
  6. Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth (Cell)
  7. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer (New England Journal of Medicine)
  8. Mutational signatures associated with tobacco smoking in human cancer (Science)
  9. Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study (The Lancet Oncology)
  10. Oncogenic kinase signalling (Nature)

Their papers